BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29999149)

  • 1. [Contrast-enhanced spectral mammography. Experience in 465 examinations].
    Navarro ME; Razmilic D; Araos I; Rodrigo A; Andia ME
    Rev Med Chil; 2018 Feb; 146(2):141-149. PubMed ID: 29999149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease.
    Lee-Felker SA; Tekchandani L; Thomas M; Gupta E; Andrews-Tang D; Roth A; Sayre J; Rahbar G
    Radiology; 2017 Nov; 285(2):389-400. PubMed ID: 28654337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced Digital Mammography: A Single-Institution Experience of the First 208 Cases.
    Lewis TC; Pizzitola VJ; Giurescu ME; Eversman WG; Lorans R; Robinson KA; Patel BK
    Breast J; 2017 Jan; 23(1):67-76. PubMed ID: 27696576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
    Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
    Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced spectral mammography in patients with MRI contraindications.
    Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
    Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine.
    Pediconi F; Catalano C; Occhiato R; Venditti F; Fraioli F; Napoli A; Kirchin MA; Passariello R
    Radiology; 2005 Oct; 237(1):45-56. PubMed ID: 16126926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.
    Tardivel AM; Balleyguier C; Dunant A; Delaloge S; Mazouni C; Mathieu MC; Dromain C
    Breast J; 2016 Sep; 22(5):520-8. PubMed ID: 27345656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.
    Tsigginou A; Gkali C; Chalazonitis A; Feida E; Vlachos DE; Zagouri F; Rellias I; Dimitrakakis C
    Br J Radiol; 2016 Nov; 89(1067):20160397. PubMed ID: 27452266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts.
    Mori M; Akashi-Tanaka S; Suzuki S; Daniels MI; Watanabe C; Hirose M; Nakamura S
    Breast Cancer; 2017 Jan; 24(1):104-110. PubMed ID: 26942415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging.
    Strahle DA; Pathak DR; Sierra A; Saha S; Strahle C; Devisetty K
    Breast Cancer Res Treat; 2017 Apr; 162(2):283-295. PubMed ID: 28138893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal Breast Lesions in Clinical CT Examinations of the Chest: A Retrospective Analysis.
    Krug KB; Houbois C; Grinstein O; Borggrefe J; Puesken M; Hanstein B; Malter W; Maintz D; Hellmich M
    Rofo; 2017 Oct; 189(10):977-989. PubMed ID: 28683503
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
    Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
    Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management.
    Houben IP; Vanwetswinkel S; Kalia V; Thywissen T; Nelemans PJ; Heuts EM; Smidt ML; Meyer-Baese A; Wildberger JE; Lobbes M
    Acta Radiol; 2019 Sep; 60(9):1110-1117. PubMed ID: 30678480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of low-dose photon-counting contrast-enhanced tomosynthesis with spectral imaging.
    Schmitzberger FF; Fallenberg EM; Lawaczeck R; Hemmendorff M; Moa E; Danielsson M; Bick U; Diekmann S; Pöllinger A; Engelken FJ; Diekmann F
    Radiology; 2011 May; 259(2):558-64. PubMed ID: 21330558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.